PTPA and intrahepatic cholangiocarcinoma: We confirmed that MC‐LR was able to inhibit the activity of PP2A and activate MEK‐ERK signalling pathway via up‐regulating the expression of SET, resulting in the ICC cell proliferation and poor prognosis.